SPRY4 and non-small cell lung carcinoma: In our study, we demonstrated that miR-17-92 cluster can significantly promote the development of NSCLC by inhibiting SPRY4, and there is a synergistic effect between the members of miR-17-92 cluster in vitro and in vivo.